FDA May Announce New Warning on Johnson & Johnson COVID-19 Vaccine Related to Guillain-Barré Syndrome, a Rare Autoimmune Disorder: Washington Post Report
The Food and Drug Administration is preparing to announce a new warning for the Johnson & Johnson COVID-19 vaccine related to Guillain-Barré Syndrome, a rare autoimmune disorder.
New Warning on Johnson & Johnson COVID-19 Vaccine:
SCOOP: FDA expected to announce new warning on Johnson & Johnson vaccine linked to rare autoimmune disorder, Guillain-Barre syndrome. About 100 reports of GBS detected after 12.8 million doses. Most people fully recover from GBS. @lauriemcginley2 + me. https://t.co/NHMHyGAzg0
— LenaSun (@bylenasun) July 12, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Jul 12, 2021 11:41 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
